21 - Pharmaceutical industry

Statistics     Section C     Division 21

1 - General information

95 companies 0.0%
0 employees 0.0%
~ 0 employees
per company

2 - Income statement

Average % Trend
Out of taxes turnover K$ 462 100% +6.5%
Purchases & stocks variance K$ -135 -29% +3.3 points
Gross margin K$ 327 71% -3.3 points
Operating expenses & revenues K$ -196 -42% -4.5 points
Taxes and subsidies K$ 5 1% -0.1 points
Value added at factor costs K$ 122 26% -0.1 points
Wages costs  (1 employee = $ 0) K$ -128 -28% -1.2 points
Gross operating surplus K$ -6 -1% +1.1 points
Depreciation and provisions K$ -13 -3% +1.0 points
Operating income K$ -19 -4% +0.1 points
Financial incomes and costs K$ 253 55% -66.5 points
Earnings before taxes K$ -272 -59% -66.5 points
Exceptional incomes and costs K$ -125 -27% +298.7 points
Income tax K$ 7 1% -11.0 points
Net income K$ -391 -84% -354.2 points
Self-financing capacity K$ -6 -1% +13.9 points

3 - Balance sheet

Assets Average % Liabilities Average %
Gross intangible assets M$ 0.4 31% Equity M$ 0.0 1%
Of which goodwill M$ 0.2 19% Of which share capital M$ 0.2 13%
Gross tangible assets M$ 0.1 10% Bank loans M$ 1.0 76%
Of which lands M$ 0.0 0%
Gross financial capital assets M$ 0.5 38%
Depreciations M$ -1.5 -122%
Net fixed assets M$ -0.5 -44% Permanent capital M$ 1.0 77%
Stocks M$ 0.1 7% Payables M$ 0.1 10%
Receivables M$ 0.3 22% Other liabilities M$ 0.2 13%
Cash M$ 1.5 118%
Other assets M$ 0.0 -4%
Current assets M$ 1.8 144% Short term debts M$ 0.3 23%
total assets M$ 1.3 100% total liabilities M$ 1.3 100%

4 - Cash

Average % Turnover
Stocks  (stock cover : 94 days) M$ 0.1 19%
Receivables  (payment terms : 179 - 215 days) M$ 0.3 60%
Other assets M$ 0.0 -10%
Payables  (payment terms : 106 - 127 days) M$ -0.1 -26%
Other liabilities M$ -0.2 -36%
Net working capital (A) M$ 0.0 7%
Permanent capital M$ 1.0 208%
Net fixed assets M$ 0.5 118%
Working capital (B) M$ 1.5 326%
Cash (B - A) M$ 1.5 319%

5 - Profitability analysis

Asset turnover ratio
Turnover M$ 0.5
Assets M$ 1.3
37%
Profit rate

Operating income M$ 0.0
Turnover M$ 0.5
-4.1%
Return on investment
Operating income M$ 0.0
Assets M$ 1.3
-1.5%